Digital Health Global

MARCH 26, 2024

Through end-to-end joint development endeavours with biotech & pharmaceutical companies, Indivi is poised to continue its growth and success in the nascent digital biomarker industry and lead the field of science in digital measurements for neuroscience R&D.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Digital Health Global

MARCH 1, 2023

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

Pharmaceuticals 88

Pharmaceuticals Leadership BioTech Digital Health 88

Health Populi

APRIL 24, 2018

Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma.

BioTech 185

BioTech Life Science Nursing Mental health 185

Healthcare IT Today

JANUARY 8, 2024

It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.

Health IT 82

Health IT Drug Development Pharmaceuticals BioTech 82

Society for Participatory Medicine

FEBRUARY 1, 2023

Our honeymoon commenced in April with what some pharmaceutical sponsors refer to as a “mandate” to show proof of a diversity, equity, and inclusion plan “as soon as practical” in the new drug application process, further solidified by the passage of the omnibus spending package at the end of 2022.

BioTech 144

BioTech Drug Development Meaningful Use Pharmaceuticals 144

Health Populi

JULY 11, 2019

In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Demonstrating the blur between hospitals, insurance and pharma, Civica Rx appointed Martin VanTrieste, formerly Chief Quality Officer at Amgen, as CEO. Xellia, FYI, is based in Denmark.

Life Science 220

Life Science BioTech Medicare Pharmaceuticals 220

Digital Health Global

AUGUST 2, 2023

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He We’re excited to have Colin join us as CEO and Director of VivoSense and drive the next phase of our development. For more information, visit www.vivosense.com. We are on Twitter.

BioTech 88

BioTech Digital Health Pharmaceuticals healthcare technology 88

Health Populi

APRIL 24, 2019

In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. over-the-counter medicines); and, health insurance.

BioTech 205

BioTech Pharmaceuticals Life Science Health Information 205

Health Populi

FEBRUARY 24, 2020

And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and life science organizations. Even trust with pharmaceutical companies increased that year.

Medical Billing 225

Medical Billing Digital Health Patient Experience Life Science 225

Healthcare IT Today

AUGUST 1, 2023

Our cloud-based platform unifies patient-centric data, biometrics, diagnostic tools, patient outcomes, care delivery, practitioner engagement, pharmaceuticals, and more. A member of the Sequoia Project, Parker Health is dual headquartered in Washington, DC and Dallas, TX, with offices in Menlo Park, CA. To learn more, visit ourparker.com.

BioTech 52

BioTech FHIR Pharmaceuticals Interoperability 52

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 110

BioTech Life Science Drug Development Patient Experience 110

Health Populi

MARCH 11, 2021

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Digital Health Global

MARCH 16, 2023

Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

APRIL 4, 2023

Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins. We’ll be able to create complex protocols for studying every aspect of chronic conditions and maybe someday resolving it.

Life Science 77

Life Science BioTech Pharmaceuticals Public Health 77

Lloyd Price

DECEMBER 5, 2018

The acquisition of Tesaro will strengthen our pharmaceuticals business by accelerating the build of our oncology pipeline and commercial footprint, along with providing access to new scientific capabilities,” Emma Walmsley, Glaxo’s chief executive, said in a prepared statement.

BioTech 43

BioTech Pharmaceuticals 43

Lloyd Price

JANUARY 10, 2019

HealthTech does not include Biotech, such as protein research or pharmaceuticals, and also does not include MedDev, such as devices that are implanted into the body. HealthTech defines the intersection between healthcare and technology and is also sometimes referred to as digital health. Source : [link]

BioTech 56

BioTech Pharmaceuticals Digital Health 56

Digital Health Global

JANUARY 30, 2023

About Mark Cuban Cost Plus Drug Company The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. Collaboration focuses on pricing transparency, affordable access, and engaging patients at home to ensure treatment adherence.

BioTech 88

BioTech Pharmaceuticals Digital Health Public Health 88

Digital Health Global

SEPTEMBER 27, 2023

Lodo Therapeutics (acquired by Zymergen, now Ginkgo BioWorks), Petra Pharma (acquired by a global pharmaceutical company), Proniras Corporation, and Rodeo Therapeutics (acquired by Amgen Inc.). About ClavystBio ClavystBio’s mission is to accelerate the commercialization of life science breakthroughs into health impact.

Life Science 88

Life Science Drug Development HC BioTech 88

Lloyd Price

NOVEMBER 2, 2018

In October 2018, pharmaceutical giant Pfizer and private-equity firm Bain Capital LP announced the formation of Cerevel Therapeutics LLC, a drug-discovery collaboration for central nervous system disorders. Pfizer aims to invest $150 million in biotech startups focused on neurometabolic disorders, neurodegeneration, and neuroinflammation.

BioTech 40

BioTech Pharmaceuticals 40

Lloyd Price

DECEMBER 8, 2018

Existing investors include biotech giant Celgene Corp. , and pharmaceutical entrepreneur Robert Duggan. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say. DNA-sequencing company Illumina Inc.,

Pharmaceuticals 56

Pharmaceuticals Life Science BioTech Drug Development 56

Digital Health Global

JUNE 20, 2023

With this fundraising, BrainTale aims to provide physicians and pharmaceutical companies with innovative solutions to improve the diagnosis, monitoring and prediction of neurological diseases and disorders, in particular Alzheimer’s and Parkinson’s disease, amyotrophic lateral sclerosis and traumatic brain injury.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Society for Participatory Medicine

JANUARY 11, 2022

As a leader in patient advocacy, I am often asked to speak on the topic of patient centricity and patient advocacy from the biotech/pharma perspective. What do we mean by patient centricity or when we say that patients are at the center of what we do or patients are our guiding star?

Drug Development 89

Drug Development BioTech Patient Experience Pharmaceuticals 89

Insulin Nation

NOVEMBER 4, 2016

According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. Novo Nordisk was considered the last major player in the pharmaceutical industry working towards the development of oral insulin. Trick or treat!

BioTech 65

BioTech Pharmaceuticals 65

MedTech Boston

OCTOBER 15, 2019

Framingham, Massachusetts will be home to global pharmaceutical giant Sanofi’s newly. Photo has been modified. Courtesy of Sanofi. The post Sanofi Opens Massachusetts-Based Digitally-Enabled Drug Manufacturing Facility appeared first on MedTech Boston.

Pharmaceuticals 40

Pharmaceuticals BioTech 40

Insulin Nation

AUGUST 12, 2014

Landing a $925 million deal might seem like good news…unless youre in the pharmaceutical world. Sanofi put down $150 million to get the product rollout started, according to Fierce Biotech , and that money is really just an advance for Mannkind to pay most of its share of the costs of the rollout.

BioTech 88

BioTech Pharmaceuticals 88

Lloyd Price

SEPTEMBER 16, 2023

The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments.

Life Science 67

Life Science Digital Health BioTech Health Technology 67

Mobi Health News

FEBRUARY 18, 2022

The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.

Life Science 239

Life Science BioTech Pharmaceuticals 239

Lloyd Price

FEBRUARY 13, 2024

The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments. These initiatives are helping to create a supportive environment for healthtech companies to thrive. "At

Healthcare Innovation 64

Healthcare Innovation Digital Health Life Science healthcare technology 64

Lloyd Price

SEPTEMBER 2, 2023

This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. Consolidation of the healthcare industry: The healthcare industry is consolidating, as larger companies acquire smaller ones in order to gain market share and scale.

Life Science 64

Life Science Digital Health EHR BioTech 64

Insulin Nation

NOVEMBER 4, 2016

According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. Novo Nordisk was considered the last major player in the pharmaceutical industry working towards the development of oral insulin. Trick or treat!

BioTech 40

BioTech Pharmaceuticals 40

Digital Health Global

JUNE 20, 2023

Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. has been a senior executive/CEO, as well as a chairman, board member, and entrepreneur in multiple public and private biotech and pharma companies in the U.S. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

FierceHealthIT

AUGUST 29, 2023

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

Pharmaceuticals 96

Pharmaceuticals BioTech Medicare 96

Lloyd Price

NOVEMBER 10, 2018

One of the biggest gambles in biotech history is about to be tested on Wall Street. In its prospectus, Moderna set an initial target of $500 million for the offering, which would make it the largest biotech IPO in history. Unlike a typical biotech going public, Moderna has a pipeline of 21 programs, 10 of which are in human testing.

BioTech 52

BioTech Pharmaceuticals 52

Health Populi

MAY 4, 2023

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. is always a detailed, deep, and insightful dive into the state of prescription drugs.

Public Health 156

Public Health Mental health Life Science Telehealth 156

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 91

Drug Development Pharmaceuticals Life Science BioTech 91